Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 October 2024 | Story André Damons | Photo Supplied
Prof-Maryke-Labuschagne
Prof Maryke Labuschagne is a Professor of Plant Breeding in the UFS Department of Plant Sciences.

A new research chair at the University of the Free State (UFS), led by Prof Maryke Labuschagne, a Professor of Plant Breeding in the UFS Department of Plant Sciences, hopes to increase food and nutritional security in South Africa through crops that have intrinsic high nutritional value.

The Breeding Climate-Resilient Vegetables and Grains research chair was established in partnership with the Agricultural Research Council (ARC) and the Department of Agriculture, Land Reform and Rural Development (DALRRD). It will be hosted within the Faculty of Natural and Agricultural Sciences (NAS) alongside the other ARC-DALLRD-UFS research chairs, namely Climate Change and Agriculture, Innovative Agro-processing for Climate-smart Food System, Agriculture Risk Financing and Sustainable Livestock Production. 

The aim of the new ARC-DALLRD-UFS research chair, explains Prof Labuschagne, who is also leading the National Research Foundation (NRF) SARChI Chair in Diseases and Quality of Field Crops, is to breed climate resilient crops with high levels of nutrients such as iron, zinc, provitamin A and essential amino acids, as well as disease resistance, in collaboration with the ARC.

Breeding of climate resilient crops

“We are all aware of the need for food security in South Africa. Climate change is already negatively impacting food production. With this research chair, in collaboration with the ARC, we hope to increase food security through crops that have intrinsic high nutritional value, for example, high levels of iron and zinc and provitamin A, of which there are high levels of deficiency in our population, and at the same time increase climate resilience (such as heat and drought tolerance) in these crops.

“We will be working on breeding climate-resilient, nutrient-rich and disease-resistant pigeon pea and cowpea cultivars; maize rich in provitamin A, iron and zinc; highly nutritious sweet and bitter sorghum; rust-resistant and good-quality wheat; high-yielding and nutritious indigenous vegetables such as amaranth and amadumbi; and research on potato, sweet potato and cassava for human and industrial uses,” says Prof Labuschagne.

The new chair will complement the research that is already being done for the SARChI chair, but with the ARC as partner. It will combine the expertise and resources of Plant Breeding at the UFS with that of the ARC-VIMP (Vegetable, Industrial and Medicinal Plants), ARC-GC (Grain Crops) and ARC-SC (Small Grains). The chair research will include orphan crops such as cowpea, pigeon pea and indigenous vegetables, as well as root and tuber crops such as potato and cassava, and cereals such as wheat, maize and sorghum.

Collaborative research

“The focus of this chair is on collaborative research and student training with the ARC, but the research area will still focus on the development of nutrient-rich and disease-resistant food-security crops. It will also have an additional focus of climate resilience, and the inclusion of orphan crops indigenous to Africa and South Africa.”

Prof Labuschagne says it is exciting that collaborative research can now be done with the unique expertise and resources (laboratory equipment, fields, greenhouses etc.) of several research institutes for the benefit of food and nutritional security in South Africa. Doing this research in a large team with lots of expertise in different areas will certainly yield more and better results with a larger impact on food security.

“This is a very exciting development in agricultural research now that we are part of a large team all working towards the same goal of improving food security, sharing expertise and resources and also doing collaborative training of MSc and PhD students who will become the scientists of tomorrow, taking this quest into the future.”

Prof Vasu Reddy, Deputy Vice-Chancellor: Research and Internationalisation, says this chair is aligned to the UFS Vision 130 strategy, shaped by excellence and impact, sustainability and society. “This distinguished chair led by Prof Labuschagne recognises exceptional achievement and pre-eminence in the field to catalyse and ignite new talent and new knowledge. It marks an exciting opportunity to deepen our understanding of breeding climate-resilient vegetables and grains aligned to our expertise in agriculture.”

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept